These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5410705)

  • 1. Dose, time, volume relationships in squamous cell carcinoma of the supraglottic larynx.
    Shukovsky LJ
    Am J Roentgenol Radium Ther Nucl Med; 1970 Jan; 108(1):27-9. PubMed ID: 5410705
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx.
    Maciejewski B; Taylor JM; Withers HR
    Radiother Oncol; 1986 Dec; 7(4):323-6. PubMed ID: 3809591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T3-4 squamous cell carcinoma of the larynx treated with radiation therapy alone.
    Mendenhall WM
    Semin Radiat Oncol; 1998 Oct; 8(4):262-9. PubMed ID: 9873104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local control and site of failure in radically irradiated supraglottic laryngeal cancer.
    Ghossein NA; Bataini JP; Ennuyer A; Stacey P; Krishnaswamy V
    Radiology; 1974 Jul; 112(1):187-92. PubMed ID: 4832491
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiation necrosis of the larynx. Etiology and management.
    Stell PM; Morrison MD
    Arch Otolaryngol; 1973 Aug; 98(2):111-3. PubMed ID: 4723761
    [No Abstract]   [Full Text] [Related]  

  • 6. Laryngeal carcinoma. IV. Analysis of treatment results using the Cohen model.
    Hjelm-Hansen M
    Acta Radiol Oncol; 1980; 19(1):3-12. PubMed ID: 6246727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy of cancer of the larynx.
    Lederman M
    J Laryngol Otol; 1970 Sep; 84(9):867-96. PubMed ID: 5471893
    [No Abstract]   [Full Text] [Related]  

  • 8. [Exclusive radiotherapy in 250 cases of stage I-II cancers of the supraglottic larynx].
    Glínski B; Reinfuss M; Walasek T; Skolyszewski J
    Bull Cancer Radiother; 1996; 83(3):177-9. PubMed ID: 8977571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present status of the time factor in clinical radiotherapy. II. The nominal standard dose formula.
    Fletcher GH; Barkley HT; Shukovsky LJ
    J Radiol Electrol Med Nucl; 1974 Nov; 55(11):748-51. PubMed ID: 4452951
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiotherapy for carcinoma of the supraglottis.
    Mendenhall WM; Parsons JT; Stringer SP; Cassisi NJ
    Otolaryngol Clin North Am; 1997 Feb; 30(1):145-61. PubMed ID: 8995142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperfractionated radiotherapy of early vocal cord cancer--adverse radiogenic reactions].
    Herrmann T; Alheit HD; Jochem I; Lesche A; Tölle D; Flach M
    Radiobiol Radiother (Berl); 1987; 28(3):297-307. PubMed ID: 3310083
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of pre-operative radiotherapy for supraglottic larynx cancer.
    Hendrickson FR; Liebner E
    Ann Otol Rhinol Laryngol; 1968 Apr; 77(2):222-9. PubMed ID: 4967479
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiation tolerance of the normal tissues of the larynx. Its implications in radiotherapy.
    Aristizabal SA; Caldwell WL
    Radiology; 1972 May; 103(2):419-22. PubMed ID: 5024571
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary radiotherapy for carcinoma in situ and early invasive carcinoma of the glottic larynx.
    Sung DI; Chang CH; Harisiadis L; Rosenstein LM
    Int J Radiat Oncol Biol Phys; 1979 Apr; 5(4):467-72. PubMed ID: 110752
    [No Abstract]   [Full Text] [Related]  

  • 15. The place of radiotherapy in the management of the squamous cell carcinoma of the supraglottic larynx.
    Fletcher GH; Jesse RH; Lindberg RD; Koons CR
    Am J Roentgenol Radium Ther Nucl Med; 1970 Jan; 108(1):19-26. PubMed ID: 4188900
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
    Eriksen JG; Steiniche T; Overgaard J;
    Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of dose per fraction and estimation of an alpha/beta value for the late complications of the vocal cord.
    Deore SM; Supe SJ; Sharma V; Dinshaw KA
    Strahlenther Onkol; 1991 Oct; 167(10):608-11. PubMed ID: 1948646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of autograft in atypical resection of the larynx after radical radiotherapy].
    Klochikhin AL; Markov GI
    Vestn Otorinolaringol; 1995; (4):46-7. PubMed ID: 7676561
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinoma of the larynx. Results of radiation therapy in 213 patients.
    Goffinet DR; Eltringham JR; Glatstein E; Bagshaw MA
    Am J Roentgenol Radium Ther Nucl Med; 1973 Mar; 117(3):553-64. PubMed ID: 4693017
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx.
    Maciejewski B; Preuss-Bayer G; Trott KR
    Int J Radiat Oncol Biol Phys; 1983 Mar; 9(3):321-8. PubMed ID: 6841183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.